Inspire Medical Systems, Inc.·4

Dec 23, 4:15 PM ET

Herbert Timothy P. 4

4 · Inspire Medical Systems, Inc. · Filed Dec 23, 2024

Insider Transaction Report

Form 4
Period: 2024-12-20
Herbert Timothy P.
DirectorCEO and President
Transactions
  • Other

    Stock Option (Right to Buy)

    2024-12-2027,25451,913 total(indirect: By LLC)
    Exercise: $42.15Exp: 2028-12-18Common Stock (27,254 underlying)
  • Other

    Stock Option (Right to Buy)

    2024-12-2013,70326,100 total(indirect: By LLC)
    Exercise: $194.82Exp: 2030-12-14Common Stock (13,703 underlying)
  • Other

    Stock Option (Right to Buy)

    2024-12-202,9155,553 total(indirect: By LLC)
    Exercise: $227.53Exp: 2030-12-14Common Stock (2,915 underlying)
  • Other

    Stock Option (Right to Buy)

    2024-12-2028,84054,934 total(indirect: By LLC)
    Exercise: $71.00Exp: 2029-12-16Common Stock (28,840 underlying)
  • Other

    Common Stock

    2024-12-2061,770117,658 total(indirect: By LLC)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $194.82Exp: 2030-12-14Common Stock (17,100 underlying)
    17,100
  • Common Stock

    9,690
  • Common Stock

    (indirect: By Trust)
    63,658
  • Stock Option (Right to Buy)

    Exercise: $71.00Exp: 2029-12-16Common Stock (9,128 underlying)
    9,128
  • Stock Option (Right to Buy)

    Exercise: $227.53Exp: 2030-12-14Common Stock (12,220 underlying)
    12,220
Footnotes (5)
  • [F1]Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions.
  • [F2]Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports.
  • [F3]Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
  • [F4]The option is fully vested and exercisable.
  • [F5]The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Documents

1 file
  • 4
    tm2431875-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT